[Interaction of topotecan, DNA topoisomerase I inhibitor, with double-stranded polydeoxyribonucleotides. 4. Topotecan binds preferably to the GC base pairs of DNA].
Interaction of topotecan (TPT) with synthetic double-stranded polydeoxyribonucleotides has been studied in solutions of low ionic strength at pH = 6.8 by linear flow dichroism (LD), circular dichroism (CD), UV-Vis absorption and Raman spectroscopy. The complexes of TPT with poly(dG-dC).poly(dG-dC), poly(dG).poly(dC), poly(dA-dC).poly(dG-dT), poly(dA).poly(dT) and previously studied by us complexes of TPT with calf thymus DNA and coliphage T4 DNA have been shown to have negative LD in the long-wavelength absorption band of TPT, whereas the complex of TPT with poly(dA-dT).poly(dA-dT) has positive LD in this absorption band of TPT. Thus, there are two different types of TPT complexes with the polymers. TPT has been established to bind preferably to GC base pairs because its affinity to the polymers of different GC composition decreases in the following order: poly(dG-dC).poly(dG-dC) > poly(dG).poly(dC) > poly(dA-dC).poly(dG-dT) > poly(dA).poly(dT). The presence of DNA has been shown to shift monomer-dimer equilibrium in TPT solutions toward dimer formation. Several duplexes of the synthetic polynucleotides bound together by the bridges of TPT dimers may participate in the formation of the studied type of TPT-polynucleotide complexes. Molecular models of TPT complex with linear and ring supercoiled DNAs and with deoxyguanosine have been considered. TPT (and presumably all camptothecin family) proved to be a representative of a new class of DNA-specific ligands whose biological action is associated with formation of dimeric bridges between two DNA duplexes.
Strel'tsov
S A
SA
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia. strelcov@imb.ac.ru
Mikheĭkin
A L
AL
Grokhovskiĭ
S L
SL
Oleĭnikov
V A
VA
Kudelina
I A
IA
Zhuze
A L
AL
D020029:Base Pairing; D001665:Binding Sites; D002942:Circular Dichroism; D004247:DNA / Q000737:chemistry* / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000378:metabolism*; D008958:Models, Molecular; D009690:Nucleic Acid Conformation; D009994:Osmolar Concentration; D011089:Polydeoxyribonucleotides / Q000737:chemistry* / Q000378:metabolism*; D012996:Solutions; D013059:Spectrum Analysis, Raman; D059004:Topoisomerase I Inhibitors; D019772:Topotecan / Q000737:chemistry / Q000378:metabolism*
D004791:Enzyme Inhibitors; D011089:Polydeoxyribonucleotides; D012996:Solutions; D059004:Topoisomerase I Inhibitors; D019772:Topotecan; D004247:DNA